Pharmacy
New Colorado Law Allows Doctors to Recommend Medical Marijuana for Disabling Medical Conditions
Colorado lawmakers passed Senate Bill 19-013 (Concerning the Conditions for Medical Marijuana Use For Disabling Conditions, and, in connection therewith, Adding a Condition for Which a Physician Could Prescribe an Opioid to the List of Disabling Medical Conditions for Medical Marijuana Use) in May 2019 and it took effect August 2, 2019. Senate Bill 19-013 allows doctors…
Read MoreFDA Issues Warning Letter to Curaleaf Over Its CBD Products
Last week, the Food and Drug Administration (FDA) sent a regulatory ‘Warning Letter‘ to Curaleaf, Inc. (Curaleaf) regarding its cannabidiol (CBD) containing products. CBD and tetrahydrocannabinol (THC) are two natural compounds found in cannabis or marijuana plants. CBD is a non-psychoactive compound, meaning that it doesn’t produce the high or sense of euphoria associated with…
Read MoreAmerican Society for Pharmacy Law
Baer Law Firm is a proud legal sponsor of the 2019 American Society for Pharmacy Law Developments in Pharmacy Law Seminar.
Read MoreElectronic Prescribing of Controlled Substances in Colorado
Earlier this year, Colorado Governor Polis signed SB 19-079 Concerning a Requirement that Certain Practitioners Prescribe Controlled Substances Electronically into law. The new law requires that physicians, physician assistants, advanced nurse practitioners, dentists, podiatrists and optometrists must prescribe Schedule II, III, or IV controlled substances electronically, with certain exceptions. A few exceptions noted in the…
Read MoreDispensing Chronic Maintenance Drug Without a Prescription
In March, Colorado Governor Polis signed House Bill 19-1077 Authorization for a Pharmacist to Dispense a Chronic Maintenance Drug to a Patient without a Current Prescription in Limited Circumstances. The new law, effective immediately, allows a pharmacist to dispense an emergency supply of a chronic maintenance drug to a patient without a current valid prescription…
Read MoreColorado Board of Pharmacy to Regulate Pharmacy Technicians
In early June 2019, Colorado Governor Jared Polis signed HB 19-1242: Concerning the Regulation of Pharmacy Technicians by the State Board of Pharmacy. The new laws takes effect on October 1, 2019, and requires pharmacy technicians practicing in Colorado to obtain a certification or provisional certification from the Colorado State Board of Pharmacy (Board) on…
Read MoreColorado Pharmacy Technician Bill Passes House and Senate
Earlier this month both the Colorado House and Senate passed House Bill 19-1242 (HB19-1242) which will allow the Colorado State Board of Pharmacy (Board) to regulate pharmacy technicians in Colorado. By March 30, 2020, pharmacy technicians practicing in Colorado must obtain certification from the Board by providing: Proof of certification by a Board-approved, nationally recognized…
Read MoreColorado Pharmacy Technician Regulation Bill: Update
There are currently about 8,000 pharmacy technicians practicing in Colorado. House Bill 19-1242 (HB 1242), as discussed previously on the Baer Law Blog, requires pharmacy technicians practicing in Colorado on or after June 15, 2020, to obtain certification from the Colorado State Board of Pharmacy (Board) in the Department of Regulatory Agencies. If HB 1242…
Read MoreColorado House Bill 19-1242: Regulation of Pharmacy Technicians by the State Board of Pharmacy
Earlier this week, a bipartisan bill, House Bill 19-1242 (HB19-1242), Concerning the Regulation of Pharmacy Technicians by the State Board of Pharmacy, was introduced in the in Colorado House of Representatives and assigned to the Health and Insurance Committee. The Colorado Board of Pharmacy is one of only a handful of states that do not…
Read MoreNABP Statement on Prescription Drug Importation Proposals
Last month the National Association of Boards of Pharmacy (NABP) released a ‘Statement on Prescription Drug Importation Proposals‘ reiterating its stance that prescription drug importation is not a viable solution to addressing high prescription drug costs. The NABP statement is in response to recent policymaker proposals seeking to allow (1) the importation of prescription drugs…
Read More